Our experts at In Vivo have rounded up the latest in dealmaking news and insights including what big pharma is seeking in strategic partners, highlights of the biggest deal makers of 2023, recent private equity and VC investments, and much more.
To enable the booking feature, please enable all cookies in your browser.